These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15863976)

  • 1. [Evaluation of AUC(0-4) predictive methods for cyclosporine in kidney transplant patients].
    Aoyama T; Matsumoto Y; Shimizu M; Fukuoka M; Kimura T; Kokubun H; Yoshida K; Yago K
    Yakugaku Zasshi; 2005 May; 125(5):441-7. PubMed ID: 15863976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients.
    Tokui K; Kimata T; Uchida K; Yuasa H; Hayashi Y; Itatsu T; Nabeshima T
    Ther Drug Monit; 2004 Jun; 26(3):287-94. PubMed ID: 15167630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
    Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients.
    Le Guellec C; Bourgoin H; Büchler M; Le Meur Y; Lebranchu Y; Marquet P; Paintaud G
    Clin Pharmacokinet; 2004; 43(4):253-66. PubMed ID: 15005639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010.
    Kokuhu T; Fukushima K; Ushigome H; Yoshimura N; Sugioka N
    Int J Med Sci; 2013; 10(12):1665-73. PubMed ID: 24151438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
    Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC
    Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics.
    Wacke R; Rohde B; Engel G; Kundt G; Hehl EM; Bast R; Seiter H; Drewelow B
    Eur J Clin Pharmacol; 2000 Apr; 56(1):43-8. PubMed ID: 10853876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A compartmental pharmacokinetic model of cyclosporin and its predictive performance after Bayesian estimation in kidney and simultaneous pancreas-kidney transplant recipients.
    Cremers SC; Scholten EM; Schoemaker RC; Lentjes EG; Vermeij P; Paul LC; den Hartigh J; de Fijter JW
    Nephrol Dial Transplant; 2003 Jun; 18(6):1201-8. PubMed ID: 12748356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pharmacokinetics of cyclosporine A in cadaveric and living-related renal transplant recipients and in an experimental rat model of renal failure.
    Sugioka N; Fujimoto K; Tanaka Y; Fukushima K; Ito Y; Kokuhu T; Okamoto M; Yoshimura N; Takada K
    Drug Metab Lett; 2009 Aug; 3(3):152-61. PubMed ID: 19702545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.
    Zhao W; Fakhoury M; Baudouin V; Maisin A; Deschênes G; Jacqz-Aigrain E
    Ther Drug Monit; 2011 Dec; 33(6):681-7. PubMed ID: 22011724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of cyclosporine area under the curve using a three-point sampling strategy after Neoral administration.
    Gaspari F; Anedda MF; Signorini O; Remuzzi G; Perico N
    J Am Soc Nephrol; 1997 Apr; 8(4):647-52. PubMed ID: 10495795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure.
    Primmett DR; Levine M; Kovarik JM; Mueller EA; Keown PA
    Ther Drug Monit; 1998 Jun; 20(3):276-83. PubMed ID: 9631924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
    Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T
    Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients.
    Fruit D; Rousseau A; Amrein C; Rollé F; Kamar N; Sebbag L; Redonnet M; Epailly E; Marquet P; Prémaud A
    Clin Pharmacokinet; 2013 Apr; 52(4):277-88. PubMed ID: 23400901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.
    Monchaud C; Rousseau A; Leger F; David OJ; Debord J; Dantoine T; Marquet P
    Eur J Clin Pharmacol; 2003 Apr; 58(12):813-20. PubMed ID: 12698308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
    Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
    Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of different pharmacokinetics including relationship among AUC, peak, and trough levels between cyclosporine and tacrolimus in renal transplant recipients using new pharmacokinetic parameter--why cyclosporine is monitored by C(2) level and tacrolimus by trough level--.
    Takeuchi H; Matsuno N; Senuma K; Hirano T; Yokoyama T; Taira S; Kihara Y; Kuzuoka K; Konno O; Jojima Y; Mejit A; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Ashizawa T; Nagao T; Toraishi T; Okuyama K; Oka K; Unezaki S
    Biol Pharm Bull; 2008 Jan; 31(1):90-4. PubMed ID: 18175948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.